ed; prp/shockwave; cocktail trial

"This is a phase 1 clinical trial, so we're primarily looking at safety and adverse events. We’ve had none in the 46 participants that we have so far," says David Alejandro Velasquez. https://www.urologytimes.com/view/experts-highlight-preliminary-findings-from-the-cocktail-trial-in-ed In this...